Physician profile
Darren Hoffberger
NPI 1598774390
$9,339.40
in general payments reported to CMS, 2019-2025
63 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,866 · 2020: $1,000 · 2021: $1,404 · 2022: $1,099 · 2023: $1,241 · 2024: $1,175 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,853 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,853.14 |
| Education | $117.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $889.72 | 2019-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $594.64 | 2019-2025 | |
| Novo Nordisk INC | $589.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Insmed, INC. | $498.62 | 2019-2025 | Arikayce, Brinsupri |
| Pfizer INC. | $464.83 | 2019-2025 | |
| Glaxosmithkline, LLC. | $436.88 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $411.83 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $403.17 | 2020-2025 | Mounjaro, Kisunla, Jardiance |
| Astrazeneca Pharmaceuticals LP | $348.54 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $347.58 | 2019-2023 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $338.95 | 2020-2025 | Glassia, Cuvitru, Gattex |
| Novartis Pharmaceuticals Corporation | $330.33 | 2022-2025 | |
| Exact Sciences Corporation | $273.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Paratek Pharmaceuticals, INC. | $268.62 | 2019-2023 | Nuzyra |
| Philips North America LLC | $234.10 | 2019-2025 | Holter, Ecc Solutions, Event |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Hoffberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.